Skip to content
StakeZone

Users Discontinuing Weight-Loss Medications Regain Weight Far More Rapidly Than Those on Conventional Diets

Illustration of medical injection and scale
Weight management involves ongoing approaches.

Fresh analysis indicates that patients who stop using new slimming jabs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who end traditional lifestyle programs.

Research printed in a prominent health publication points out that while overweight individuals often shed about a fifth of their total mass while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"Users purchasing such medications must be cognizant of the danger of quick weight regain when the medication concludes," warns expert Dr. Susan Jebb.

This pace of regain means a reversion to original mass in about 18 months.

Weighing Therapies

The research, which looked at 37 of studies involving over 9,000 of participants, compared the results of these new drugs with older methods.

The team note that individuals who lose weight through dieting generally see a less rapid creep back—perhaps 100 grams monthly—once they finish.

The Reason for the Quick Rebound

Nutrition scientists suggest the mechanism of the drugs is key to understanding the amplified regain.

The injections mimic a natural hormone called GLP-1, which helps regulate hunger.

"Sustained high doses of the hormone levels several times higher than normal may cause the body to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.

"Discontinuation of this hormone supplement results in hunger is no longer kept in check, making overeating far more likely."

An Ongoing Issue?

Health authorities recommend the injections for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.

Many experts contend that, given the likelihood of weight regain, the treatment is often long-term.

This opinion is reinforced by pharmaceutical companies, who note that the findings "emphasize the long-term nature of obesity," akin to managing diseases like diabetes.

User Testimonies

Users who have stopped the medication explain a intense return of hunger.

"It was like a switch that goes on and you're instantly extremely hungry," said one woman.

The struggle is worsened if individuals have not established lasting dietary or behavioural changes during treatment.

Growing Use

Recent estimates suggest that millions of people in the UK have used these injections in the last 12 months, with demand remaining high.

  • Use is more common among women compared to males.
  • The 40s and 50s age group shows the greatest usage rates.
  • A large proportion obtain the drugs through private healthcare rather than the NHS.

Finally, experts emphasize that while the jabs are effective tools for weight loss, they are not a permanent cure and long-term success relies on ongoing lifestyle changes.

About the author

Mark Hernandez

Alex Morgan is a seasoned sports betting analyst with over a decade of experience in the UK gambling industry.

StakeZone

Type to search articles.